A study of women on long-term hormone replacement therapy and their attitude to suggested cessation

References

• North American Menopause Society. Amended report from the NAMS Advisory Panel on postmenopausal hormone therapy. Menopause 2003; 10: 6–12
   PubMed Web of Science ®Google Scholar
• Royal College of Physicians of Edinburgh. Consensus conference on hormone replacement therapy. Final consensus statement, http://www. rcpe. ac.uk/education/standards/consensus/hrt_03.php
   Google Scholar
• Fournier A, Berrino F, Riboli E, Avenel V, Clavel-Chapelon F. Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort. Int J Cancer 2004; 114: 448–454
   Web of Science ®Google Scholar
• Beral V, Doll R, Key T. Collaborative Group on Hormonal Factors in Breast Cancer and Hormone Replacement Therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer. Lancet 1997; 350: 1047–1059
   PubMed Web of Science ®Google Scholar
• Walter F M, Britten N. Patients' understanding of risk: a qualitative study of decision-making about the menopause and hormone replacement therapy in general practice. Fam Pract 2002; 19: 579–586
   PubMed Web of Science ®Google Scholar
• Sinclair H K, Bond C M, Taylor R J. Hormone replacement therapy: a study of women's knowledge and attitudes. Br J Gen Pract 1993; 159: 365–370
   Google Scholar
• Kaplan B, Yogev Y, Sulkas J, Geva A, Nahum R, Fisher M. Attitude towards health and hormone replacement therapy among female obstetrician-gynaecologists in Israel. Maturitas 2002; 43: 113–116
   PubMed Web of Science ®Google Scholar
• Beral V for the Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003; 362: 419–427
   PubMed Web of Science ®Google Scholar
• Rossouw J E, Anderson G L, Prentice R L, , for Writing Group for the Women's Health Initiative Investigators, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321–333
   PubMed Web of Science ®Google Scholar
• Panay N, Studd J WW. The psychotherapeutic effects of estrogens. Gynecol Endocrinol 1998; 12: 353–365
   PubMed Web of Science ®Google Scholar
• Studd J WW, Panay N. Hormones and depressive women. Climacteric 2004; 7: 338–346
   PubMed Web of Science ®Google Scholar
• Montgomery J C, Appleby L, Brincat M, Versi E, Tapp A, Fenwick P BC, Studd J WW. Effect of oestrogen and testosterone implants in climacteric. Lancet 1987; I: 297–299
   Google Scholar
• Manson J E, Hsia J, Johnson K C, , for Women's Health Initiative Investigators, et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003; 349: 523–534
   PubMed Web of Science ®Google Scholar
• Speroff L. WHI estrogen-only arm is cancelled. Maturitas 2004; 48: 3–4
   PubMed Web of Science ®Google Scholar
• Studd J WW. Second thoughts on the Women's Health Initiative study: the effect of age on the safety of HRT. Climacteric 2004; 7: 412–414
   PubMed Web of Science ®Google Scholar
• Welton A, Hepworth J, Collins N, et al. Decision-making about hormone replacement therapy by women in England and Scotland. Climacteric 2004; 7: 41–49
   PubMed Web of Science ®Google Scholar
• Sands R, Studd J WW. Exogenous androgens in postmenopausal women. Am J Med 1995; 98(Suppl 1A)76S–79S
   PubMedGoogle Scholar
• Davison S L, Davis S R. Androgens in women. J Steroid Biochem Mol Biol 2003; 85: 363–366
   PubMed Web of Science ®Google Scholar
• Rivera-Woll L M, Papalia M, Davis S R, Burger H G. Androgen insufficiency in women: diagnostic and therapeutic implications. Hum Reprod Update 2004; 10: 421–432
   PubMed Web of Science ®Google Scholar
• Roberts L W, Fromm L M, Bartlik B D. Sexuality of women through the life phases. Textbook of Women's Health, L A Wallis. Lippincott-Raven, Philadelphia 1998; 763–780
   Google Scholar
• Studd J WW, Collins W P, Chakravati S, Newton J R, Oram D, Parsons A. Oestradiol and testosterone implants in the treatment of psychosexual problems in the postmenopausal women. Br J Obstet Gynaecol 1977; 84: 314–316
   Google Scholar
• Grodstein F, Manson J E, Colditz G A, Willett W C, Speizer F E, Stampfer M J. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med 2000; 133: 933–941
   PubMed Web of Science ®Google Scholar
• Burger H G. Androgen production in women. Fertil Steril 2002; 77: 3–5
   PubMed Web of Science ®Google Scholar
• North American Menopause Society. The role of testosterone therapy in postmenopausal women: position statement of The North American Menopause Society. Menopause 2005; 12: 496–511
   PubMed Web of Science ®Google Scholar
• Shifren J L. The role of androgens in female sexual dysfunction. Mayo Clin Proc 2004; 79(Suppl 4)S19–S24
   PubMed Web of Science ®Google Scholar
• Nappi R E, Detaddei S, Ferdeghini F, Brundu B, Sommacal A, Polatti F. Role of testosterone in feminine sexuality. J Endocrinol Invest 2003; 26(Suppl 3)97–101
   PubMedGoogle Scholar
• Khastgir G, Studd J WW, Holland N, Alaghband-Zadeh J, Sims T J, Bailey A J. Anabolic effect of long-term oestrogen replacement on bone collagen in elderly postmenopausal women with osteoporosis. Osteoporos Int 2001; 12: 465–470
   PubMed Web of Science ®Google Scholar